≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Ovarian dysfunction: androgen excess, drug-induced

Endpoint Browser

E4_ODANDRO_ADVERSE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

only females

313377

2. Check conditions

None

313377

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — E28.1#

1 out of 7 registries used, show all original rules.

8

4. Check minimum number of events

None

8

5. Include endpoints

None

8

6. Filter based on genotype QC (FinnGen only)

6

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
E28
Name in latin
Hypersecretio androgenorum

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 6 6 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 24.86 24.86 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
0
19
0.00
0.74
0.0
1.8
—
—
—
0
0
0
10
0.00
0.23
0.0
1.3
—
—
—
0
0
0
10
0.00
0.23
0.0
1.3
—
—
—
0
0
0
10
0.00
0.23
0.0
1.3
—
—
—
0
0
0
10
0.00
0.23
0.0
1.1
—
—
—
0
0
0
10
0.00
0.23
0.0
2.9
—
—
—
0
0
0
10
0.00
0.23
0.0
1.3
—
—
—
0
0
0
10
0.00
0.23
0.0
6.6
—
103.50
—
0
10
0
12
0.00
0.23
0.0
1.5
—
—
—
0
0
0
9
0.00
0.23
0.0
2.6
—
—
—
0
0
0
9
0.00
0.23
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
10.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
8.7
—
0.87
—
0
6
0
8
0.00
0.00
0.0
2.9
—
1.84
—
0
8
0
6
0.00
0.00
0.0
12.8
—
9.85
—
0
6
0
6
0.00
0.00
0.0
2.8
—
25.78
—
0
6
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
7
63
+∞
-0.00
5.6
4.9
6.16
5.51
mmol/l
—
7
58
0
5
0.00
-0.00
0.0
4.0
—
36.92
—
0
5
0
7
0.00
-0.00
0.0
3.4
—
3.81
—
0
7
7
70
0.00
-0.00
12.4
22.2
28.86
29.93
pg
—
7
70
7
63
+∞
-0.00
10.0
15.5
331.29
330.16
g/l
—
7
63
7
70
0.00
-0.00
12.4
22.4
287.43
262.51
e9/l
—
7
70
0
5
0.00
-0.00
0.0
3.0
—
2.88
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
70
0.00
-0.00
12.4
22.9
43.71
40.13
%
—
7
70
7
70
0.00
-0.00
12.4
22.5
144.86
132.91
g/l
—
7
70
0
7
0.00
-0.00
0.0
3.4
—
6.03
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
70
0.00
-0.00
12.4
22.3
87.00
90.37
fl
—
7
70

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: E4_ODANDRO_ADVERSE – Ovarian dysfunction: androgen excess, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).